decentralized trial SOP – Clinical Research Made Simple

SOP for Cybersecurity and Privacy in Decentralized Trials

digi — Fri, 10 Oct 2025 05:00:23 +0000

SOP for Cybersecurity and Privacy in Decentralized Trials

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-cybersecurity-and-privacy-in-decentralized-trials”
},
“headline”: “SOP for Cybersecurity and Privacy in Decentralized Trials”,
“description”: “This SOP defines procedures for ensuring cybersecurity and data privacy in decentralized clinical trials. It establishes controls for secure platforms, encryption, user access management, data protection, and compliance with FDA, EMA, GDPR, HIPAA, CDSCO, WHO, and ICH GCP guidelines.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Cybersecurity and Privacy in Decentralized Trials

SOP No.	CR/OPS/125/2025
Supersedes	NA
Page No.	1 of 72
Issue Date	26/08/2025
Effective Date	01/09/2025
Review Date	01/09/2026

Purpose

The purpose of this SOP is to define cybersecurity and privacy measures for decentralized clinical trials. It establishes controls for securing clinical trial data, ensuring confidentiality of subject information, preventing unauthorized access, and meeting international regulatory requirements.

Scope

This SOP applies to sponsors, CROs, investigators, site staff, IT vendors, and QA teams involved in decentralized and hybrid clinical trials. It covers secure system design, encryption, authentication, monitoring, incident management, and compliance with HIPAA, GDPR, FDA Part 11, and ICH GCP.

Responsibilities

Sponsor: Ensures cybersecurity systems are validated and vendors comply with requirements.
Investigator: Ensures confidentiality of subject data collected remotely.
CRO: Oversees decentralized platform security and audits vendors.
IT Vendor: Provides secure infrastructure with validated encryption and monitoring systems.
QA: Audits cybersecurity and privacy systems for compliance.
Data Protection Officer: Ensures GDPR/HIPAA compliance and handles breach notifications.

Accountability

The Sponsor’s Chief Information Security Officer (CISO) is accountable for cybersecurity systems in decentralized trials. Investigators remain accountable for subject data collected at the site or remotely.

Procedure

1. System Validation
1.1 Validate IT systems for Part 11/GDPR compliance.
1.2 Record in System Validation Log (Annexure-1).

2. Encryption
2.1 Use end-to-end encryption for all subject data transmissions.
2.2 Maintain Encryption Log (Annexure-2).

3. User Authentication and Access Control
3.1 Implement multi-factor authentication (MFA).
3.2 Assign role-based access controls.
3.3 Maintain User Access Log (Annexure-3).

4. Cybersecurity Monitoring
4.1 Monitor systems for unauthorized access and breaches.
4.2 Maintain Monitoring Log (Annexure-4).

5. Incident Reporting
5.1 Report cybersecurity incidents within 24 hours.
5.2 Record incidents in Incident Log (Annexure-5).
5.3 Notify regulators per GDPR/HIPAA requirements.

6. Staff Training
6.1 Conduct regular cybersecurity and privacy training.
6.2 Maintain Training Log (Annexure-6).

7. Audit and Inspection Readiness
7.1 Conduct periodic audits of cybersecurity measures.
7.2 Maintain Audit Log (Annexure-7).

8. Archiving
8.1 Archive cybersecurity logs and incident reports in TMF and ISF.
8.2 Retain per regulatory timelines.

Abbreviations

SOP: Standard Operating Procedure
CRO: Contract Research Organization
QA: Quality Assurance
CISO: Chief Information Security Officer
TMF: Trial Master File
ISF: Investigator Site File
GDPR: General Data Protection Regulation
HIPAA: Health Insurance Portability and Accountability Act
FDA: Food and Drug Administration
EMA: European Medicines Agency
CDSCO: Central Drugs Standard Control Organization

Documents

System Validation Log (Annexure-1)
Encryption Log (Annexure-2)
User Access Log (Annexure-3)
Monitoring Log (Annexure-4)
Incident Log (Annexure-5)
Training Log (Annexure-6)
Audit Log (Annexure-7)

References

Version: 1.0

Approval Section

Prepared By	Ravi Kumar, IT Security Specialist
Checked By	Sunita Reddy, QA Officer
Approved By	Dr. Anil Sharma, Head Clinical Operations

Annexures

Annexure-1: System Validation Log

Date	System	Validation Status	Reviewed By
01/09/2025	Decentralized Trial Platform v5.0	Validated	QA Officer

Annexure-2: Encryption Log

Date	System	Encryption Type	Reviewed By
02/09/2025	Trial Database	AES-256	IT Security

Annexure-3: User Access Log

Date	User ID	Role	Access Level	Status
03/09/2025	MON-01	Monitor	Read Only	Active

Annexure-4: Monitoring Log

Date	System	Activity Monitored	Reviewed By	Status
04/09/2025	Trial Platform	Unauthorized Access Attempts	CISO	Blocked

Annexure-5: Incident Log

Date	Incident	Impact	Action Taken	Status
05/09/2025	Suspicious Login	Low	Blocked and Investigated	Closed

Annexure-6: Training Log

Date	Staff Name	Training Topic	Trainer	Status
06/09/2025	Site Staff	Cybersecurity Awareness	IT Security	Completed

Annexure-7: Audit Log

Date	System	Audit Type	Auditor	Status
07/09/2025	Trial Platform	Quarterly Cybersecurity Audit	QA Team	Completed

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
26/08/2025	00	Initial version	New SOP creation	Head Clinical Operations

For more SOPs visit: Pharma SOP

SOP for Remote/Central SDV for Decentralized Trials

digi — Wed, 08 Oct 2025 13:56:26 +0000

SOP for Remote/Central SDV for Decentralized Trials

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-remote-central-sdv-for-decentralized-trials”
},
“headline”: “SOP for Remote/Central SDV for Decentralized Trials”,
“description”: “This SOP defines standardized procedures for remote and central source data verification (SDV) in decentralized clinical trials. It ensures compliance with FDA, EMA, CDSCO, WHO, and ICH GCP, covering secure data access, monitoring, audit trails, privacy, and inspection readiness.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Remote/Central SDV for Decentralized Trials

SOP No.	CR/OPS/122/2025
Supersedes	NA
Page No.	1 of 66
Issue Date	26/08/2025
Effective Date	01/09/2025
Review Date	01/09/2026

Purpose

The purpose of this SOP is to establish standardized procedures for remote and central source data verification (SDV) in decentralized clinical trials. Remote/central SDV ensures data quality, regulatory compliance, and subject safety while reducing the need for onsite monitoring.

Scope

This SOP applies to sponsors, CROs, investigators, monitors, data managers, and QA staff involved in decentralized clinical trials. It covers processes for remote access to source data, central monitoring workflows, data verification, audit trails, and regulatory inspection readiness.

Responsibilities

Sponsor: Provides oversight, ensures technology compliance, and approves monitoring plans.
Investigator: Grants secure access to source data and ensures subject confidentiality.
Monitor: Conducts remote SDV and documents findings in monitoring reports.
CRO: Manages monitoring platforms and coordinates with sites.
QA: Audits remote SDV processes and ensures compliance with regulations.

Accountability

The Sponsor’s Clinical Data Management Head is accountable for remote and central SDV oversight. Investigators are accountable for ensuring data accuracy and access compliance at site level.

Procedure

1. Planning and Preparation
1.1 Develop a monitoring plan specifying remote and central SDV procedures.
1.2 Document in Remote Monitoring Plan Log (Annexure-1).

2. Secure Data Access
2.1 Provide authorized monitors with role-based secure access to EHRs and eSource systems.
2.2 Maintain access details in Secure Access Log (Annexure-2).

3. Source Data Verification (SDV)
3.1 Verify subject-level data (e.g., demographics, visit dates, lab results) remotely.
3.2 Document findings in Remote SDV Log (Annexure-3).

4. Central Monitoring
4.1 Conduct data trend analysis across multiple sites.
4.2 Identify outliers or protocol deviations.
4.3 Document in Central Monitoring Log (Annexure-4).

5. Data Privacy and Confidentiality
5.1 Comply with GDPR, HIPAA, and local data protection rules.
5.2 Mask identifiers where possible.
5.3 Maintain entries in Data Privacy Compliance Log (Annexure-5).

6. Audit Trail and Documentation
6.1 Maintain audit trails of all remote access and SDV activities.
6.2 Record in Audit Trail Log (Annexure-6).

7. Reporting
7.1 Generate remote monitoring reports within 10 working days of activity.
7.2 File in TMF and ISF.

8. Inspection Readiness
8.1 Ensure all SDV records are inspection-ready.
8.2 Document inspection simulations in Inspection Readiness Log (Annexure-7).

Abbreviations

SOP: Standard Operating Procedure
SDV: Source Data Verification
CRO: Contract Research Organization
QA: Quality Assurance
EHR: Electronic Health Record
TMF: Trial Master File
ISF: Investigator Site File
GCP: Good Clinical Practice
GDPR: General Data Protection Regulation
HIPAA: Health Insurance Portability and Accountability Act
FDA: Food and Drug Administration
EMA: European Medicines Agency
CDSCO: Central Drugs Standard Control Organization

Documents

Remote Monitoring Plan Log (Annexure-1)
Secure Access Log (Annexure-2)
Remote SDV Log (Annexure-3)
Central Monitoring Log (Annexure-4)
Data Privacy Compliance Log (Annexure-5)
Audit Trail Log (Annexure-6)
Inspection Readiness Log (Annexure-7)

References

Version: 1.0

Approval Section

Prepared By	Ravi Kumar, Clinical Data Manager
Checked By	Sunita Reddy, QA Officer
Approved By	Dr. Anil Sharma, Head Clinical Operations

Annexures

Annexure-1: Remote Monitoring Plan Log

Date	Protocol ID	Prepared By	Status
01/09/2025	DEC-TRIAL-01	Monitor	Approved

Annexure-2: Secure Access Log

Date	User ID	System Accessed	Role	Status
02/09/2025	MON-01	EHR System	Monitor	Active

Annexure-3: Remote SDV Log

Date	Subject ID	Data Verified	Verified By	Status
03/09/2025	S101	Visit 1 Labs	Monitor	Confirmed

Annexure-4: Central Monitoring Log

Date	Analysis Performed	Reviewed By	Status
04/09/2025	Protocol Deviation Trends	Data Manager	Reviewed

Annexure-5: Data Privacy Compliance Log

Date	System	Measure	Reviewed By	Status
05/09/2025	EHR System	Encryption	QA Officer	Compliant

Annexure-6: Audit Trail Log

Date	User ID	Activity	System	Status
06/09/2025	MON-01	SDV Completed	EHR System	Logged

Annexure-7: Inspection Readiness Log

Date	Agency	Simulation	Performed By	Status
07/09/2025	EMA	Mock Inspection	QA Team	Completed

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
26/08/2025	00	Initial version	New SOP creation	Head Clinical Operations

For more SOPs visit: Pharma SOP